TENS: Is it powerful in diminishing spasticity in Different Sclerosis?.

Uploaded on:
Category: News / Events
TENS: Is it viable in decreasing spasticity in Multiple Sclerosis? . The Ayrshire Multiple Sclerosis Service. Caledonian University, Glasgow. The Multiple Sclerosis Society. Linda Miller Senior Physiotherapist. TENS.
Slide 1

TENS: Is it viable in diminishing spasticity in Multiple Sclerosis? The Ayrshire Multiple Sclerosis Service. Caledonian University, Glasgow. The Multiple Sclerosis Society. Linda Miller Senior Physiotherapist

Slide 2

TENS Transcutaneuos Electrical Nerve Stimulation : Electrical incitement of low power, high recurrence with short heartbeat widths specifically animates vast breadth (Group II), mechanosensative surface nerve endings. Components of activity : segmental restraint, arrival of endogenous opiods, physiological blocking, fake treatment.

Slide 3

Spasticity & TENS Evidence of progress in neurophysiological measures post TENS. Decrease in spasticity in stroke & SCI. Constrained examination in MS. Clinical experience of lessening in fit.

Slide 4

Aims of the study To figure out if TENS was viable in decreasing spasticity in Multiple Sclerosis. To figure out if TENS was powerful for muscle fit or torment connected with spasticity . To figure out if application time affects the general viability of TENS. To build up conventions for future studies

Slide 5

Study Design 32 patients from Ayrshire MS administration. Rehashed hybrid outline. Subjects haphazardly doled out 2 gathers All subjects utilized TENS for 2 weeks, 60 min for each day and for 2 weeks, 8 hrs for every day. Single visually impaired (assessor). TENS 100Hz, 0.125ms, persistent heartbeat over quadriceps muscle.

Slide 6

Study Design

Slide 7

Outcome Measures Demographic information Global Spasticity Score (Ash+PTR+ Clonus) Modified Penne Spasm Score Visual Analog Score Compliance journal Questionnaire

Slide 8

Data Analysis A 2 test T - test was utilized to check the likeness of the demographic & standard variables of the 2 bunches (Mann-Whitney:not ordinary). A 3-variable ANOVA(GSS) used to build up that there was no contrast between 2 bunches. A combined Wilcoxin was performed on the before & after information (GSS,PSS,VAS) from both gatherings for 60 min & 8 hrs.

Slide 9

Results 1 No huge contrast between the 2 bunches for gauge & demographic information No sig diff between the gatherings (p=0.765) No sig diff in the GSS taking after TENS (60 min & 8hrs) and in the PSS & VAS taking after TENS (60 min)

Slide 10

Results 2: However! Mean scores diminished post TENS, with scores decreasing after 8hrs >60min TENS. Huge lessening in PSS & VAS taking after TENS (8hrs) p 0.05. Wide variability in all scores : more subjects with scores diminished after 8hrs:60min TENS.

Slide 11

Changes in GSS, PSS & VAS post TENS

Slide 12

Questionnaire Results The larger part of subjects felt TENS had diminished manifestations (88% for fit). 72% reported advantages enduring 2-3 days subsequent to ceasing TENS. 81% showed they would keep on using TENS. Most wanted to utilize <8 hrs Long term follow up TENS(9 - 21mths) 56% as yet utilizing.

Slide 13

Conclusion No factually critical diminishments in spasticity in spite of the fact that the lion\'s share of subjects showed clinically huge decreases. TENS is best for fit & torment connected with spasticity. TENS is more successful when utilized for more applications. TENS is all around endured and simple to utilize.

Slide 14

Future Implications The potential for indication decrease, joined with diminished solution related intricacies and costs makes TENS a treatment worth considering in the general administration of individuals with mellow to direct spasticity in Multiple Sclerosis.

View more...